A Supercomputer Exchange: The Supercomputer Era

THE SUPERCOMPUTER ERA Sidney Kann and Noms Parker Smith. Harcourt Brace Jovanovich, Cambridge, MA, 1987. 313 pp. $19.95. Supercomputers are not new. They have been in existence since the invention of computers. Today, however, they have become indispensable tools at the cutting edge of science and technology. They enable scientists to solve problems and develop new technologies for tomorrow’s industry, affecting national employment patterns, wealth and national security. Until recent

Written byChristopher Lazou
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Sidney Kann and Noms Parker Smith.
Harcourt Brace Jovanovich, Cambridge,
MA, 1987. 313 pp. $19.95.

Supercomputers are not new. They have been in existence since the invention of computers. Today, however, they have become indispensable tools at the cutting edge of science and technology. They enable scientists to solve problems and develop new technologies for tomorrow’s industry, affecting national employment patterns, wealth and national security.

Until recently the manufacture of supercomputers was the preserve of the United States. The Japanese entry into the market early in 1983 sent shockwaves throughout U.S. industry and government. Spurred on by media hype and $200 million in funding from the National Science Foundation, new centers at American universities are enabling researchers in science and industry to exploit the enormous power of supercomputers.

Of the 17 supercomputer centers recently set up in the United States, the National Science Foundation is able to support only 10. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies